MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Genkyotex Announces Successful Phase Ia Data with First in Class NOX Inhibitor GKT137831.
Brennan CaruthersJune 22, 2012
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Pronota's Risk Stratification Test Breaks New Ground in the Early Detection of Pre-term Pre-eclampsia.

Brennan CaruthersJuly 9, 2012
Next

Pronota Strengthens Management Team Former VP Corporate Development Genzyme joins as CBO.

Brennan CaruthersMarch 16, 2012

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact